216 related articles for article (PubMed ID: 34904285)
1. RANKL Blockade Reduces Cachexia and Bone Loss Induced by Non-Metastatic Ovarian Cancer in Mice.
Pin F; Jones AJ; Huot JR; Narasimhan A; Zimmers TA; Bonewald LF; Bonetto A
J Bone Miner Res; 2022 Mar; 37(3):381-396. PubMed ID: 34904285
[TBL] [Abstract][Full Text] [Related]
2. Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia.
Pin F; Barreto R; Kitase Y; Mitra S; Erne CE; Novinger LJ; Zimmers TA; Couch ME; Bonewald LF; Bonetto A
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):685-700. PubMed ID: 30009406
[TBL] [Abstract][Full Text] [Related]
3. Withaferin A ameliorates ovarian cancer-induced cachexia and proinflammatory signaling.
Straughn AR; Kakar SS
J Ovarian Res; 2019 Nov; 12(1):115. PubMed ID: 31767036
[TBL] [Abstract][Full Text] [Related]
4. Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway.
Shen Q; Kuang JX; Miao CX; Zhang WL; Li YW; Zhang XW; Liu X
Phytomedicine; 2022 Jan; 95():153858. PubMed ID: 34861585
[TBL] [Abstract][Full Text] [Related]
5. PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia.
Pin F; Novinger LJ; Huot JR; Harris RA; Couch ME; O'Connell TM; Bonetto A
FASEB J; 2019 Jun; 33(6):7778-7790. PubMed ID: 30894018
[TBL] [Abstract][Full Text] [Related]
6. Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study.
Luan Y; Zhang Y; Yu SY; You M; Xu PC; Chung S; Kurita T; Zhu J; Kim SY
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1289-1301. PubMed ID: 35044098
[TBL] [Abstract][Full Text] [Related]
7. MC38 Tumors Induce Musculoskeletal Defects in Colorectal Cancer.
Huot JR; Pin F; Essex AL; Bonetto A
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540821
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-Based Follistatin Messenger RNA Therapy for Reprogramming Metastatic Ovarian Cancer and Ameliorating Cancer-Associated Cachexia.
Korzun T; Moses AS; Kim J; Patel S; Schumann C; Levasseur PR; Diba P; Olson B; Rebola KGO; Norgard M; Park Y; Demessie AA; Eygeris Y; Grigoriev V; Sundaram S; Pejovic T; Brody JR; Taratula OR; Zhu X; Sahay G; Marks DL; Taratula O
Small; 2022 Nov; 18(44):e2204436. PubMed ID: 36098251
[TBL] [Abstract][Full Text] [Related]
9. Curcumin Targeting NF-
Zhang J; Zheng J; Chen H; Li X; Ye C; Zhang F; Zhang Z; Yao Q; Guo Y
Mediators Inflamm; 2022; 2022():2567150. PubMed ID: 35132306
[TBL] [Abstract][Full Text] [Related]
10. IFIT2-depleted metastatic oral squamous cell carcinoma cells induce muscle atrophy and cancer cachexia in mice.
Lai KC; Hong ZX; Hsieh JG; Lee HJ; Yang MH; Hsieh CH; Yang CH; Chen YR
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1314-1328. PubMed ID: 35170238
[TBL] [Abstract][Full Text] [Related]
11. Preclinical Models for Studying the Impact of Macrophages on Cancer Cachexia.
Markov SD; Gonzalez D; Mehla K
Curr Protoc Pharmacol; 2020 Dec; 91(1):e80. PubMed ID: 33264501
[TBL] [Abstract][Full Text] [Related]
12. Ovarian cancer ascites induces skeletal muscle wasting in vitro and reflects sarcopenia in patients.
Ubachs J; van de Worp WRPH; Vaes RDW; Pasmans K; Langen RC; Meex RCR; van Bijnen AAJHM; Lambrechts S; Van Gorp T; Kruitwagen RFPM; Olde Damink SWM; Rensen SS
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):311-324. PubMed ID: 34951138
[TBL] [Abstract][Full Text] [Related]
13. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.
Judge SM; Deyhle MR; Neyroud D; Nosacka RL; D'Lugos AC; Cameron ME; Vohra RS; Smuder AJ; Roberts BM; Callaway CS; Underwood PW; Chrzanowski SM; Batra A; Murphy ME; Heaven JD; Walter GA; Trevino JG; Judge AR
Cancer Res; 2020 May; 80(9):1861-1874. PubMed ID: 32132110
[TBL] [Abstract][Full Text] [Related]
14. Matrine improves skeletal muscle atrophy by inhibiting E3 ubiquitin ligases and activating the Akt/mTOR/FoxO3α signaling pathway in C2C12 myotubes and mice.
Chen L; Chen L; Wan L; Huo Y; Huang J; Li J; Lu J; Xin B; Yang Q; Guo C
Oncol Rep; 2019 Aug; 42(2):479-494. PubMed ID: 31233199
[TBL] [Abstract][Full Text] [Related]
15. Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release.
Zhou L; Zhang T; Shao W; Lu R; Wang L; Liu H; Jiang B; Li S; Zhuo H; Wang S; Li Q; Huang C; Lin D
Skelet Muscle; 2021 Jul; 11(1):17. PubMed ID: 34229732
[TBL] [Abstract][Full Text] [Related]
16. Muscle weakness and selective muscle atrophy in osteoprotegerin-deficient mice.
Hamoudi D; Bouredji Z; Marcadet L; Yagita H; Landry LB; Argaw A; Frenette J
Hum Mol Genet; 2020 Feb; 29(3):483-494. PubMed ID: 31943048
[TBL] [Abstract][Full Text] [Related]
17. Role of myokines and osteokines in cancer cachexia.
Pin F; Bonewald LF; Bonetto A
Exp Biol Med (Maywood); 2021 Oct; 246(19):2118-2127. PubMed ID: 33899538
[TBL] [Abstract][Full Text] [Related]
18. ACVR2B antagonism as a countermeasure to multi-organ perturbations in metastatic colorectal cancer cachexia.
Huot JR; Pin F; Narasimhan A; Novinger LJ; Keith AS; Zimmers TA; Willis MS; Bonetto A
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1779-1798. PubMed ID: 33200567
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of Ovarian Cancer-Associated Cachexia.
Callaway CS; Mouchantat LM; Bitler BG; Bonetto A
Endocrinology; 2023 Nov; 165(1):. PubMed ID: 37980602
[TBL] [Abstract][Full Text] [Related]
20. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model.
Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG
J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
